Selected research
Market Structure
Global Enasidenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enasidenib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enasidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enasidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enasidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enasidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enasidenib include Bristol Myers Squibb. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enasidenib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enasidenib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enasidenib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enasidenib market size, projected growth trends, production technologies, key applications, and end-use industries.
Enasidenib Segment by Company
Bristol Myers Squibb
Enasidenib Segment by Type
100mg
50mg
Enasidenib Segment by Application
Hospital
Pharmacy
Enasidenib Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enasidenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enasidenib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enasidenib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enasidenib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enasidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enasidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enasidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg
- 50mg
Applications
- Hospital
- Pharmacy
Companies covered
- Bristol Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enasidenib Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enasidenib Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enasidenib Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enasidenib Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enasidenib Market Dynamics
- 2.1 Enasidenib Industry Trends
- 2.2 Enasidenib Industry Drivers
- 2.3 Enasidenib Industry Opportunities and Challenges
- 2.4 Enasidenib Industry Restraints
3 Enasidenib Market by Manufacturers
- 3.1 Global Enasidenib Revenue by Manufacturers (2021-2026)
- 3.2 Global Enasidenib Sales by Manufacturers (2021-2026)
- 3.3 Global Enasidenib Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enasidenib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enasidenib Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enasidenib Manufacturers, Product Type & Application
- 3.7 Global Enasidenib Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enasidenib Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enasidenib Players Market Share by Revenue in 2025
- 3.8.3 2025 Enasidenib Tier 1, Tier 2, and Tier 3
4 Enasidenib Market by Type
- 4.1 Enasidenib Type Introduction
- 4.1.1 100mg
- 4.1.2 50mg
- 4.2 Global Enasidenib Sales by Type
- 4.2.1 Global Enasidenib Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enasidenib Sales by Type (2021-2032)
- 4.2.3 Global Enasidenib Sales Market Share by Type (2021-2032)
- 4.3 Global Enasidenib Revenue by Type
- 4.3.1 Global Enasidenib Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enasidenib Revenue by Type (2021-2032)
- 4.3.3 Global Enasidenib Revenue Market Share by Type (2021-2032)
5 Enasidenib Market by Application
- 5.1 Enasidenib Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Enasidenib Sales by Application
- 5.2.1 Global Enasidenib Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enasidenib Sales by Application (2021-2032)
- 5.2.3 Global Enasidenib Sales Market Share by Application (2021-2032)
- 5.3 Global Enasidenib Revenue by Application
- 5.3.1 Global Enasidenib Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enasidenib Revenue by Application (2021-2032)
- 5.3.3 Global Enasidenib Revenue Market Share by Application (2021-2032)
6 Global Enasidenib Sales by Region
- 6.1 Global Enasidenib Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enasidenib Sales by Region (2021-2032)
- 6.2.1 Global Enasidenib Sales by Region (2021-2026)
- 6.2.2 Global Enasidenib Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enasidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enasidenib Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enasidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enasidenib Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enasidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enasidenib Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enasidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enasidenib Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enasidenib Revenue by Region
- 7.1 Global Enasidenib Revenue by Region
- 7.1.1 Global Enasidenib Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enasidenib Revenue by Region (2021-2026)
- 7.1.3 Global Enasidenib Revenue by Region (2027-2032)
- 7.1.4 Global Enasidenib Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enasidenib Revenue (2021-2032)
- 7.2.2 North America Enasidenib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enasidenib Revenue (2021-2032)
- 7.3.2 Europe Enasidenib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enasidenib Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enasidenib Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enasidenib Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enasidenib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bristol Myers Squibb
- 8.1.1 Bristol Myers Squibb Company Information
- 8.1.2 Bristol Myers Squibb Business Overview
- 8.1.3 Bristol Myers Squibb Enasidenib Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bristol Myers Squibb Enasidenib Product Portfolio
- 8.1.5 Bristol Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enasidenib Value Chain Analysis
- 9.1.1 Enasidenib Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enasidenib Production Mode & Process
- 9.2 Enasidenib Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enasidenib Distributors
- 9.2.3 Enasidenib Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst